-
Review
March 9, 2023
- Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
- Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
- Clin Mol Hepatol. 2023;29(4):851-868.
Most-cited are based on citations from 2021 ~ 2023.
- Guideline
- KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
- Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Woo Lee, Yong Kyun Cho
- Clin Mol Hepatol. 2021;27(3):363-401. Published online June 22, 2021
-
View: 15203 Download: 1,169 Citations: 131
- 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
- Clin Mol Hepatol. 2022;28(4):583-705. Published online October 1, 2022
-
View: 6769 Download: 546 Citations: 78
- Review
- From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
- Seong Hee Kang, Yuri Cho, Soung Won Jeong, Seung Up Kim, Jin-Woo Lee
- Clin Mol Hepatol. 2021;27(2):257-269. Published online March 22, 2021
-
View: 7389 Download: 407 Citations: 60
- Original Article
- Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
- Won Sohn, Hyun Woong Lee, Sangheun Lee, Jin Hong Lim, Min Woo Lee, Chan Hyuk Park, Seung Kew Yoon
- Clin Mol Hepatol. 2021;27(1):157-174. Published online November 26, 2020
-
View: 7955 Download: 364 Citations: 55
- Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
- Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
- Clin Mol Hepatol. 2023;29(3):721-732. Published online March 22, 2023
-
View: 10285 Download: 1,276 Citations: 54
- Review
- Recent updates on the management of autoimmune hepatitis
- Atsumasa Komori
- Clin Mol Hepatol. 2021;27(1):58-69. Published online December 10, 2020
-
View: 12640 Download: 1,037 Citations: 50
- Original Article
- Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
- Na Young Lee, Min Jea Shin, Gi Soo Youn, Sang Jun Yoon, Ye Rin Choi, Hyeong Seop Kim, Haripriya Gupta, Sang Hak Han, Byoung Kook Kim, Do Yup Lee, Tae Sik Park, Hotaik Sung, Byung Yong Kim, Ki Tae Suk
- Clin Mol Hepatol. 2021;27(1):110-124. Published online December 3, 2020
-
View: 8541 Download: 439 Citations: 50
- Review
- The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future
- Yusuke Watanabe, Atsunori Tsuchiya, Shuji Terai
- Clin Mol Hepatol. 2021;27(1):70-80. Published online December 3, 2020
-
View: 10496 Download: 363 Citations: 49
- Current understanding of primary biliary cholangitis
- Atsushi Tanaka
- Clin Mol Hepatol. 2021;27(1):1-21. Published online December 3, 2020
-
View: 11240 Download: 730 Citations: 47
- Original Article
- Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
- Michael H. Le, Yee Hui Yeo, Biyao Zou, Scott Barnet, Linda Henry, Ramsey Cheung, Mindie H. Nguyen
- Clin Mol Hepatol. 2022;28(4):841-850. Published online September 19, 2022
-
View: 3701 Download: 171 Citations: 41
- Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
- Ansel Shao Pin Tang, Kai En Chan, Jingxuan Quek, Jieling Xiao, Phoebe Tay, Margaret Teng, Keng Siang Lee, Snow Yunni Lin, May Zin Myint, Benjamin Tan, Vijay K Sharma, Darren Jun Hao Tan, Wen Hui Lim, Apichat Kaewdech, Daniel Huang, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J Sanyal, Mark Muthiah, Cheng Han Ng
- Clin Mol Hepatol. 2022;28(3):483-496. Published online March 2, 2022
-
View: 5664 Download: 233 Citations: 41
- Review
- The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
- Erica Jennison, Christopher D. Byrne
- Clin Mol Hepatol. 2021;27(1):22-43. Published online December 10, 2020
-
View: 8094 Download: 408 Citations: 39
- MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
- Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Mohammed Eslam, Jacob George, Takuji Torimura
- Clin Mol Hepatol. 2022;28(2):150-163. Published online November 10, 2021
-
View: 5901 Download: 337 Citations: 37
- Original Article
- The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease
- Cheng Han Ng, Kai En Chan, Yip Han Chin, Rebecca Wenling Zeng, Pei Chen Tsai, Wen Hui Lim, Darren Jun Hao Tan, Chin Meng Khoo, Lay Hoon Goh, Zheng Jye Ling, Anand Kulkarni, Lung-Yi Loey Mak, Daniel Q Huang, Mark Chan, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J. Sanyal, Mark Muthiah
- Clin Mol Hepatol. 2022;28(3):565-574. Published online May 19, 2022
-
View: 4717 Download: 180 Citations: 35
- Review
- Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
- Gwyneth Soon, Aileen Wee
- Clin Mol Hepatol. 2021;27(1):44-57. Published online November 19, 2020
-
View: 11117 Download: 334 Citations: 35
- Guideline
- KASL clinical practice guidelines for management of chronic hepatitis B
- Clin Mol Hepatol. 2022;28(2):276-331. Published online April 1, 2022
-
DOI: https://doi.org/10.3350/cmh.2022.0084 Correction in: Clin Mol Hepatol 2022;28(4):940
-
View: 9060 Download: 537 Citations: 34
- Review
- Recent advances in nonalcoholic fatty liver disease metabolomics
- Hwi Young Kim
- Clin Mol Hepatol. 2021;27(4):553-559. Published online June 8, 2021
-
View: 8457 Download: 440 Citations: 34
- Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects
- Takuji Torimura, Hideki Iwamoto
- Clin Mol Hepatol. 2021;27(2):236-245. Published online December 3, 2020
-
View: 7226 Download: 356 Citations: 34
- Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
- Cheng Han Ng, Daniel Q. Huang, Mindie H. Nguyen
- Clin Mol Hepatol. 2022;28(4):790-801. Published online May 11, 2022
-
View: 5695 Download: 455 Citations: 33
- Original Article
- Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry
- Jong Man Kim, Deok Gie Kim, Jihyun Kim, Keunsung Lee, Kwang-Woong Lee, Je Ho Ryu, Bong-Wan Kim, Dong Lak Choi, Young Kyoung You, Dong-Sik Kim, Yang Won Nah, Koo Jeong Kang, Jai Young Cho, Geun Hong, Hee Chul Yu, Ju Ik Moon, Dongho Choi, Shin Hwang, Myoung Soo Kim
- Clin Mol Hepatol. 2021;27(3):451-462. Published online February 2, 2021
-
View: 6150 Download: 300 Citations: 32
- Scaling up the in-hospital hepatitis C virus care cascade in Taiwan
- Chung-Feng Huang, Pey-Fang Wu, Ming-Lun Yeh, Ching-I Huang, Po-Cheng Liang, Cheng-Ting Hsu, Po-Yao Hsu, Hung-Yin Liu, Ying-Chou Huang, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
- Clin Mol Hepatol. 2021;27(1):136-143. Published online December 3, 2020
-
View: 5136 Download: 172 Citations: 29
- Review
- Global incidence and prevalence of nonalcoholic fatty liver disease
- Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah
- Clin Mol Hepatol. 2023;29(Suppl):S32-S42. Published online December 14, 2022
-
View: 4870 Download: 275 Citations: 28
- Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
- Sung Won Lee, Jonggi Choi, Seung Up Kim, Young-Suk Lim
- Clin Mol Hepatol. 2021;27(3):402-412. Published online June 23, 2021
-
View: 5191 Download: 244 Citations: 28
- Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
- Karn Wijarnpreecha, Elizabeth S. Aby, Aijaz Ahmed, Donghee Kim
- Clin Mol Hepatol. 2021;27(2):221-235. Published online December 3, 2020
-
View: 6781 Download: 346 Citations: 28
- Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
- Sun Woong Kim, Jun Sik Yoon, Minjong Lee, Yuri Cho
- Clin Mol Hepatol. 2022;28(1):17-30. Published online July 20, 2021
-
View: 8266 Download: 596 Citations: 25
- Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
- Jer-Wei Wu, Jia-Horng Kao, Tai-Chung Tseng
- Clin Mol Hepatol. 2021;27(4):524-534. Published online February 23, 2021
-
View: 12280 Download: 333 Citations: 23
- Changes in the epidemiology and management of bacterial infections in cirrhosis
- Salvatore Piano, Marta Tonon, Paolo Angeli
- Clin Mol Hepatol. 2021;27(3):437-445. Published online January 28, 2021
-
View: 6431 Download: 370 Citations: 23
- Original Article
- COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
- Ka Shing Cheung, Chiu Hang Mok, Xianhua Mao, Ruiqi Zhang, Ivan FN Hung, Wai Kay Seto, Man Fung Yuen
- Clin Mol Hepatol. 2022;28(4):890-911. Published online June 3, 2022
-
View: 4263 Download: 173 Citations: 22
- Review
- β-blockers in advanced cirrhosis: More friend than enemy
- Ki Tae Yoon, Hongqun Liu, Samuel S. Lee
- Clin Mol Hepatol. 2021;27(3):425-436. Published online December 3, 2020
-
View: 5640 Download: 254 Citations: 22
- MAFLD: How is it different from NAFLD?
- Cameron Gofton, Yadhavan Upendran, Ming-Hua Zheng, Jacob George
- Clin Mol Hepatol. 2023;29(Suppl):S17-S31. Published online November 29, 2022
-
View: 6989 Download: 758 Citations: 21
